Manejo de dolor y otras condiciones con
Lasers de ERCHONIA
FDA- Erchonia Pain Market Clearances
Erchonia complies with the highest clinical testing. All Echonia level (1) clinical trials have gone through the FDA pre-IDE process, IRB approval, and are based on pilot research to ensure customers that the laser they are purchasing has been proven safe and effective by the FDA. 90% of all medical devices are substantially equivalent with no clinical research, of the 10% that are, only few submit blinded and controlled studies.
PROTOCOLS:
Addiction
Alopecia
Abdominal Pain
Acute Injury
Arthritis Pain 1
Arthritis Pain 2
Brain
Bursitis
Cartilage
Dizziness
Earache
Neurogenic Inflammation
Neuropathy 1
Neuropathy 2
Plantar Fascits
Sympathetic
Parasympathetic
Vagus Nerve
Tachycardia
TMJ Pain
Dizziness
Ear Infections
Sinusitis
Hormones Protocols
Skin
Liver
Pancreas
Gastrointestinal
Urinary Infections
Stem Cells
Post Operative Rehab 1
Post Operative Rehab 2
Scars
Sciatic 1
Sciatic 2
Toothache
Edema
Headache General
Herniated Discs
Infections
Inflammation
Injuries
Ligaments / Tendonitis
Tennis Elbow /Golf Elbow injuries
Muscle-skeletal
Nerve Root
PROVEN NON INVASIVE
DRUG-FREE THERAPY
United States Food and Drug Administration
• 2002 Chronic Neck and Shoulder Pain
• 2004 Post-Surgical Pain after Liposuction
• 2008 Post-Surgical Pain after Breast Augmentation
• 2014 Chronic Plantar Fasciitis Pain
• 2018 Chronic Low Back Pain
• 2019 Chronic Neck and Shoulder Pain using Red and Violet Laser
• 2019 Overall Nociceptive Musculoskeletal Pain
• 2021 Overall Post-operative Pain
• 2022 Chronic Neck and Shoulder Pain with green & violet
